Micro Power, a global leader in portable power solutions for mission-critical equipment, offers IronWorks, a patent pending Iron Phosphate battery solution that serves as a drop-in replacement for Sealed Lead Acid (SLA) batteries.
(Wiley-Blackwell) A new study into Staphylococcus aureus, the bacterium which is responsible for severe chronic infections worldwide, reveals how bacteria have developed a strategy of hiding within host cells to escape the immune system as well as many antibacterial treatments. The...
Built around the proven Standex GR200 ultra small magnetic reed switch, the R12575 measures just 0.379 in. length and 0.098 in. diameter, yet provides unparalleled sensitivity and performance.
From simple to complex designs, medical components custom molded of PEEK from Minnesota Rubber and Plastics (MR&P) improve performance while reducing costs.
Meller IR and Broadband Optics can be fabricated to precise customer specifications from zinc selenide and -sulfide, calcium and magnesium fluoride, germanium, silicon, sapphire, and spinel.
Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Elementâ„¢ Everolimus-Eluting StentJanuary 26, 2011 3:32 am | by Boston Scientific | News | Comments
PLATINUM China trial to support Chinese regulatory approval of next-generation platinum chromium stent
?Fourth quarter net revenues increased 6.6% sequentially; 39.9% gross margin ?2010 net income of $830 million on highest ever net revenues of $10.35 billion ?Net financial position improved $732 million in 2010 to $1.15 billion* ?Record year for the full range of ST?s ?Sense and Power?...
WellPoint says its fourth-quarter net income declined, as the prior-year period included a large gain related to a sale. Its adjusted results beat Wall Street's view.The largest publicly traded health insurer based on enrollment earned $548.8 million, or $1.40 per share, for the three months...
His Highness Sheikh Mohammed bin Zayed Al Nahyan and the Bill & Melinda Gates Foundation Partner to Immunize ChildrenJanuary 26, 2011 1:34 am | by Bio-Medicine.Org | News | Comments
SEATTLE and ABU DHABI, United Arab Emirates, Jan. 26, 2011 /PRNewswire-USNewswire/ -- His Highness Sheikh Mohammed bin Zayed Al Nahyan, the Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces, and Bill Gates, Co-Chair of the Bill & Melinda Gates Foundation,...
Global Genes Project Announces 'Wear That You Careâ„¢' Denim Awareness Campaign for Rare Disease Day 2011January 26, 2011 1:33 am | by Bio-Medicine.Org | News | Comments
DANA POINT, Calif., Jan. 26, 2011 /- Monday, February 28, 2011, is the 4th annual Rare Disease Day — a day when people worldwide will show their support for the millions of people suffering from rare diseases and disorders. According to statistics from the National Institutes...
(The Translational Genomics Research Institute) TGen Drug Development and Flagship Biosciences today announced a strategic alliance that should help speed new drugs safely into human testing and quickly benefit cancer patients.
A tiny endoscope keeps watch over a particular spot in the brain as it develops, or degenerates with disease.
One of the original biotech stars, Amgen, has reached agreement to acquire Woburn-based BioVex Group Inc. for what could total $1 billion â€“ $425 million in upfront cash and up to $575 million in additional payments based on regulatory and sales milestones.
Lexington-based RainDance Technologies Inc., a provider of microdroplet-based tools for single molecule and single cell analysis, announced that it has closed a $37.5 million Series D financing round.
Hires key inventor Brian Richardson.